391
Views
13
CrossRef citations to date
0
Altmetric
Research Articles

Physicochemical characterization of spray-dried PLGA/PEG microspheres, and preliminary assessment of biological response

&
Pages 1504-1514 | Received 04 Aug 2015, Accepted 25 Jan 2016, Published online: 02 Mar 2016
 

Abstract

Context: The use of spray-drying to prepare blended PLGA:PEG microspheres with lower immune detection.

Objective: To study physical properties, polymer miscibility and alveolar macrophage response for blended PLGA:PEG microspheres prepared by a laboratory-scale spray-drying process.

Methods: Microspheres were prepared by spray-drying 0–20% w/w ratios of PLGA 65:35 and PEG 3350 in dichloromethane. Particle size and morphology was studied using scanning electron microscopy. Polymer miscibility and residual solvent levels evaluated by thermal analysis (differential scanning calorimetry – DSC and thermogravimetric analysis – TGA). Immunogenicity was assessed in vitro by response of rat alveolar macrophages (NR8383) by the MTT-based cell viability assay and reactive oxygen species (ROS) detection.

Results: The spray dried particles were spherical, with a size range of about 2–3 µm and a yield of 16–60%. Highest yield was obtained at 1% PEG concentration. Thermal analysis showed a melting peak at 59 °C (enthalpy: 170.61 J/g) and a degradation-onset of 180 °C for PEG 3350. PLGA 65:35 was amorphous, with a Tg of 43 °C. Blended PLGA:PEG microspheres showed a delayed degradation-onset of 280 °C, and PEG enthalpy-loss corresponding to 15% miscibility of PEG in PLGA. NR8383 viability studies and ROS detection upon exposure to these cells suggested that blended PLGA:PEG microspheres containing 1 and 5% PEG are optimal in controling cell proliferation and activation.

Conclusion: This research establishes the feasibility of using a spray-drying process to prepare spherical particles (2–3 µm) of molecularly-blended PLGA 65:35 and PEG 3350. A PEG concentration of 1–5% was optimal to maximize process yield, with minimal potential for immune detection.

Disclosure statement

The authors report no declarations of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.